🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Walvax Biotechnology Co., Ltd. (SHE:300142)
China flag China · Delayed Price · Currency is CNY
10.00
-0.64 (-6.02%)
Nov 20, 2026, 3:04 PM CST

Walvax Biotechnology Revenue

Walvax Biotechnology had revenue of 312.70M CNY in the quarter ending September 30, 2026, a decrease of -44.61%. This brings the company's total for the last twelve months to 1.85B, down -23.03% year-over-year. In the year 2025, Walvax Biotechnology had annual revenue of 2.42B, down -14.29%. That makes Walvax Biotechnology the 15,132nd largest company in the world by revenue and 2,720th in China.

Revenue (ttm)
1.85B
Revenue Growth
-23.03%
P/S Ratio
8.75
Revenue / Employee
932.03K
Employees
1,981
Market Cap
15.99B

Revenue Chart

Revenue by Geography

  • Eastern China 679.27M 28.1%
  • Overseas Region 522.04M 21.6%
  • South China Region 400.71M 16.6%
  • Southwest Northwest Region 346.88M 14.3%
  • Central China Region 256.31M 10.6%
  • Northeast and North China 213.01M 8.8%
Fiscal year ended Dec 31, 2025 See the full Walvax Biotechnology breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.42B-403.21M-14.29%
Dec 31, 20242.82B-1.29B-31.41%
Dec 31, 20234.11B-972.67M-19.12%
Jan 1, 20235.09B1.62B46.89%
Jan 1, 20223.46B523.81M17.82%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.